Melanoma – a Model Disease for Scientific Innovation
Clinician-researcher Ravi K. Amaravadi, MD, recalls a time within recent memory when no therapies existed for Stage IV metastatic melanoma, and reflects upon the 17 FDA-approved therapies now available to treat the disease. In this podcast, Dr. Amaravadi notes that many of these agents— including molecularly targeted therapy, immunotherapy in solid tumors, TIL cellular therapy, and personalized mRNA cancer vaccines—were pioneered at Penn Medicine.
More From Current Show
Gynecologist oncologist Nawar Latif, MD, MPH, MSCE, offers a brief introduction to the 3rd Gynecologic Oncology Advanced Surgical...
Listen Now Leukemia specialist Matthew Connor addresses parsing the genomic determinants of the leukemias for diagnosis, and reviews the mystery...
Listen Now Head and neck reconstructive surgeon Karthik Rajasekaran, MD, and radiation oncologist Michelle Gentile, MD, discuss the nuances and...
Listen Now Dr. John Plastaras offers the insight of a clinician researcher to an engaging discussion of the emergence and...
Listen Now Neurosurgeon Christina Jackson, MD, and radiation-oncologist Emily Lebow, MD, offer their unique perspectives on recent advances in the...
Listen Now Penn radiation oncologist Alexander Lin, MD, reviews the groundbreaking clinical study that established the equivalency of proton therapy...
Listen Now Related Episodes
For patients with cancer, “immunocompromised” is not a complete assessment of infection risk. Jeremey Walker, M.D., and Emily...
Listen Now 
There seems to be many health advisories about what we can stop or start to reduce the risk...
Listen Now 
For more than 25 years, Gina Harris has had the privilege of caring for patients in emergency medicine,...
Listen Now 
Description: Wondering how finding breast cancer early affects treatment and outcomes? Julie A. Cupp, MD, Breast Disease -...
Listen Now 
After a cancer diagnosis, knowing what comes next can make a difficult time feel more manageable. Teresa Bell,...
Listen Now 
In Part 2, hear the story from the physician’s perspective. Listen in as Dr. Abby Geletzke, or “Dr....
Listen Now 
"I found an unexpected abnormal CBC — should I repeat it or refer?" This episode focuses on repeat...
Listen Now Is this mole something to worry about? Surgical oncologist, Taranjit Arora, M.D., explains how clinicians use the ABCDEs...
Listen Now 
